Aspreva Pharmaceuticals Aktie
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Aspreva Pharmaceuticals Aktie Analyse
| 05.09.07 | Aspreva Pharmaceuticals sector perform | RBC Capital Markets | |
| 28.06.07 | Aspreva Pharmaceuticals neutral | Pacific Growth Equities | |
| 01.03.07 | Aspreva Pharmaceuticals buy | Stanford Financial Group | |
| 02.10.06 | Aspreva Pharmaceuticals neutral | Merrill Lynch |
Werbung
Werbung